This report contains market size and forecasts of Anti-schizophrenic Drugs in Global, including the following market information:
Global Anti-schizophrenic Drugs Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Anti-schizophrenic Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Tablets Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Anti-schizophrenic Drugs include Pfizer, Johnson & Johnson, AstraZeneca, Eli Lilly, Otsuka Pharmaceutical, Intra-Cellular Therapies, Sunovion Pharmaceuticals, Gedeon Richter and Alkermes, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-schizophrenic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-schizophrenic Drugs Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Anti-schizophrenic Drugs Market Segment Percentages, by Type, 2022 (%)
Tablets
Capsules
Other
Global Anti-schizophrenic Drugs Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Anti-schizophrenic Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Other
Global Anti-schizophrenic Drugs Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Anti-schizophrenic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-schizophrenic Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Anti-schizophrenic Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Johnson & Johnson
AstraZeneca
Eli Lilly
Otsuka Pharmaceutical
Intra-Cellular Therapies
Sunovion Pharmaceuticals
Gedeon Richter
Alkermes
Indivior
Alexza Pharmaceuticals
Noven Pharmaceuticals
Hisamitsu Pharmaceutical
Zhejiang Huahai
Chengdu Kanghong Pharmaceutical
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-schizophrenic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-schizophrenic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-schizophrenic Drugs Overall Market Size
2.1 Global Anti-schizophrenic Drugs Market Size: 2022 VS 2030
2.2 Global Anti-schizophrenic Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-schizophrenic Drugs Players in Global Market
3.2 Top Global Anti-schizophrenic Drugs Companies Ranked by Revenue
3.3 Global Anti-schizophrenic Drugs Revenue by Companies
3.4 Top 3 and Top 5 Anti-schizophrenic Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Anti-schizophrenic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-schizophrenic Drugs Players in Global Market
3.6.1 List of Global Tier 1 Anti-schizophrenic Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Anti-schizophrenic Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Anti-schizophrenic Drugs Market Size Markets, 2022 & 2030
4.1.2 Tablets
4.1.3 Capsules
4.1.4 Other
4.2 By Type - Global Anti-schizophrenic Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti-schizophrenic Drugs Revenue, 2018-2023
4.2.2 By Type - Global Anti-schizophrenic Drugs Revenue, 2023-2030
4.2.3 By Type - Global Anti-schizophrenic Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-schizophrenic Drugs Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Other
5.2 By Application - Global Anti-schizophrenic Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti-schizophrenic Drugs Revenue, 2018-2023
5.2.2 By Application - Global Anti-schizophrenic Drugs Revenue, 2023-2030
5.2.3 By Application - Global Anti-schizophrenic Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Anti-schizophrenic Drugs Market Size, 2022 & 2030
6.2 By Region - Global Anti-schizophrenic Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti-schizophrenic Drugs Revenue, 2018-2023
6.2.2 By Region - Global Anti-schizophrenic Drugs Revenue, 2023-2030
6.2.3 By Region - Global Anti-schizophrenic Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Anti-schizophrenic Drugs Revenue, 2018-2030
6.3.2 US Anti-schizophrenic Drugs Market Size, 2018-2030
6.3.3 Canada Anti-schizophrenic Drugs Market Size, 2018-2030
6.3.4 Mexico Anti-schizophrenic Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Anti-schizophrenic Drugs Revenue, 2018-2030
6.4.2 Germany Anti-schizophrenic Drugs Market Size, 2018-2030
6.4.3 France Anti-schizophrenic Drugs Market Size, 2018-2030
6.4.4 U.K. Anti-schizophrenic Drugs Market Size, 2018-2030
6.4.5 Italy Anti-schizophrenic Drugs Market Size, 2018-2030
6.4.6 Russia Anti-schizophrenic Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Anti-schizophrenic Drugs Market Size, 2018-2030
6.4.8 Benelux Anti-schizophrenic Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Anti-schizophrenic Drugs Revenue, 2018-2030
6.5.2 China Anti-schizophrenic Drugs Market Size, 2018-2030
6.5.3 Japan Anti-schizophrenic Drugs Market Size, 2018-2030
6.5.4 South Korea Anti-schizophrenic Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Anti-schizophrenic Drugs Market Size, 2018-2030
6.5.6 India Anti-schizophrenic Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Anti-schizophrenic Drugs Revenue, 2018-2030
6.6.2 Brazil Anti-schizophrenic Drugs Market Size, 2018-2030
6.6.3 Argentina Anti-schizophrenic Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anti-schizophrenic Drugs Revenue, 2018-2030
6.7.2 Turkey Anti-schizophrenic Drugs Market Size, 2018-2030
6.7.3 Israel Anti-schizophrenic Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Anti-schizophrenic Drugs Market Size, 2018-2030
6.7.5 UAE Anti-schizophrenic Drugs Market Size, 2018-2030
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Anti-schizophrenic Drugs Major Product Offerings
7.1.4 Pfizer Anti-schizophrenic Drugs Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Anti-schizophrenic Drugs Major Product Offerings
7.2.4 Johnson & Johnson Anti-schizophrenic Drugs Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Key News
7.3 AstraZeneca
7.3.1 AstraZeneca Corporate Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Anti-schizophrenic Drugs Major Product Offerings
7.3.4 AstraZeneca Anti-schizophrenic Drugs Revenue in Global Market (2018-2023)
7.3.5 AstraZeneca Key News
7.4 Eli Lilly
7.4.1 Eli Lilly Corporate Summary
7.4.2 Eli Lilly Business Overview
7.4.3 Eli Lilly Anti-schizophrenic Drugs Major Product Offerings
7.4.4 Eli Lilly Anti-schizophrenic Drugs Revenue in Global Market (2018-2023)
7.4.5 Eli Lilly Key News
7.5 Otsuka Pharmaceutical
7.5.1 Otsuka Pharmaceutical Corporate Summary
7.5.2 Otsuka Pharmaceutical Business Overview
7.5.3 Otsuka Pharmaceutical Anti-schizophrenic Drugs Major Product Offerings
7.5.4 Otsuka Pharmaceutical Anti-schizophrenic Drugs Revenue in Global Market (2018-2023)
7.5.5 Otsuka Pharmaceutical Key News
7.6 Intra-Cellular Therapies
7.6.1 Intra-Cellular Therapies Corporate Summary
7.6.2 Intra-Cellular Therapies Business Overview
7.6.3 Intra-Cellular Therapies Anti-schizophrenic Drugs Major Product Offerings
7.6.4 Intra-Cellular Therapies Anti-schizophrenic Drugs Revenue in Global Market (2018-2023)
7.6.5 Intra-Cellular Therapies Key News
7.7 Sunovion Pharmaceuticals
7.7.1 Sunovion Pharmaceuticals Corporate Summary
7.7.2 Sunovion Pharmaceuticals Business Overview
7.7.3 Sunovion Pharmaceuticals Anti-schizophrenic Drugs Major Product Offerings
7.7.4 Sunovion Pharmaceuticals Anti-schizophrenic Drugs Revenue in Global Market (2018-2023)
7.7.5 Sunovion Pharmaceuticals Key News
7.8 Gedeon Richter
7.8.1 Gedeon Richter Corporate Summary
7.8.2 Gedeon Richter Business Overview
7.8.3 Gedeon Richter Anti-schizophrenic Drugs Major Product Offerings
7.8.4 Gedeon Richter Anti-schizophrenic Drugs Revenue in Global Market (2018-2023)
7.8.5 Gedeon Richter Key News
7.9 Alkermes
7.9.1 Alkermes Corporate Summary
7.9.2 Alkermes Business Overview
7.9.3 Alkermes Anti-schizophrenic Drugs Major Product Offerings
7.9.4 Alkermes Anti-schizophrenic Drugs Revenue in Global Market (2018-2023)
7.9.5 Alkermes Key News
7.10 Indivior
7.10.1 Indivior Corporate Summary
7.10.2 Indivior Business Overview
7.10.3 Indivior Anti-schizophrenic Drugs Major Product Offerings
7.10.4 Indivior Anti-schizophrenic Drugs Revenue in Global Market (2018-2023)
7.10.5 Indivior Key News
7.11 Alexza Pharmaceuticals
7.11.1 Alexza Pharmaceuticals Corporate Summary
7.11.2 Alexza Pharmaceuticals Business Overview
7.11.3 Alexza Pharmaceuticals Anti-schizophrenic Drugs Major Product Offerings
7.11.4 Alexza Pharmaceuticals Anti-schizophrenic Drugs Revenue in Global Market (2018-2023)
7.11.5 Alexza Pharmaceuticals Key News
7.12 Noven Pharmaceuticals
7.12.1 Noven Pharmaceuticals Corporate Summary
7.12.2 Noven Pharmaceuticals Business Overview
7.12.3 Noven Pharmaceuticals Anti-schizophrenic Drugs Major Product Offerings
7.12.4 Noven Pharmaceuticals Anti-schizophrenic Drugs Revenue in Global Market (2018-2023)
7.12.5 Noven Pharmaceuticals Key News
7.13 Hisamitsu Pharmaceutical
7.13.1 Hisamitsu Pharmaceutical Corporate Summary
7.13.2 Hisamitsu Pharmaceutical Business Overview
7.13.3 Hisamitsu Pharmaceutical Anti-schizophrenic Drugs Major Product Offerings
7.13.4 Hisamitsu Pharmaceutical Anti-schizophrenic Drugs Revenue in Global Market (2018-2023)
7.13.5 Hisamitsu Pharmaceutical Key News
7.14 Zhejiang Huahai
7.14.1 Zhejiang Huahai Corporate Summary
7.14.2 Zhejiang Huahai Business Overview
7.14.3 Zhejiang Huahai Anti-schizophrenic Drugs Major Product Offerings
7.14.4 Zhejiang Huahai Anti-schizophrenic Drugs Revenue in Global Market (2018-2023)
7.14.5 Zhejiang Huahai Key News
7.15 Chengdu Kanghong Pharmaceutical
7.15.1 Chengdu Kanghong Pharmaceutical Corporate Summary
7.15.2 Chengdu Kanghong Pharmaceutical Business Overview
7.15.3 Chengdu Kanghong Pharmaceutical Anti-schizophrenic Drugs Major Product Offerings
7.15.4 Chengdu Kanghong Pharmaceutical Anti-schizophrenic Drugs Revenue in Global Market (2018-2023)
7.15.5 Chengdu Kanghong Pharmaceutical Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Anti-schizophrenic Drugs Market Opportunities & Trends in Global Market
Table 2. Anti-schizophrenic Drugs Market Drivers in Global Market
Table 3. Anti-schizophrenic Drugs Market Restraints in Global Market
Table 4. Key Players of Anti-schizophrenic Drugs in Global Market
Table 5. Top Anti-schizophrenic Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Anti-schizophrenic Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Anti-schizophrenic Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Anti-schizophrenic Drugs Product Type
Table 9. List of Global Tier 1 Anti-schizophrenic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-schizophrenic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti-schizophrenic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Anti-schizophrenic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Anti-schizophrenic Drugs Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Anti-schizophrenic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Anti-schizophrenic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Anti-schizophrenic Drugs Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Anti-schizophrenic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Anti-schizophrenic Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Anti-schizophrenic Drugs Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Anti-schizophrenic Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Anti-schizophrenic Drugs Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Anti-schizophrenic Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Anti-schizophrenic Drugs Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Anti-schizophrenic Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Anti-schizophrenic Drugs Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Anti-schizophrenic Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Anti-schizophrenic Drugs Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Anti-schizophrenic Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Anti-schizophrenic Drugs Revenue, (US$, Mn), 2023-2030
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Anti-schizophrenic Drugs Product Offerings
Table 32. Pfizer Anti-schizophrenic Drugs Revenue (US$, Mn), (2018-2023)
Table 33. Johnson & Johnson Corporate Summary
Table 34. Johnson & Johnson Anti-schizophrenic Drugs Product Offerings
Table 35. Johnson & Johnson Anti-schizophrenic Drugs Revenue (US$, Mn), (2018-2023)
Table 36. AstraZeneca Corporate Summary
Table 37. AstraZeneca Anti-schizophrenic Drugs Product Offerings
Table 38. AstraZeneca Anti-schizophrenic Drugs Revenue (US$, Mn), (2018-2023)
Table 39. Eli Lilly Corporate Summary
Table 40. Eli Lilly Anti-schizophrenic Drugs Product Offerings
Table 41. Eli Lilly Anti-schizophrenic Drugs Revenue (US$, Mn), (2018-2023)
Table 42. Otsuka Pharmaceutical Corporate Summary
Table 43. Otsuka Pharmaceutical Anti-schizophrenic Drugs Product Offerings
Table 44. Otsuka Pharmaceutical Anti-schizophrenic Drugs Revenue (US$, Mn), (2018-2023)
Table 45. Intra-Cellular Therapies Corporate Summary
Table 46. Intra-Cellular Therapies Anti-schizophrenic Drugs Product Offerings
Table 47. Intra-Cellular Therapies Anti-schizophrenic Drugs Revenue (US$, Mn), (2018-2023)
Table 48. Sunovion Pharmaceuticals Corporate Summary
Table 49. Sunovion Pharmaceuticals Anti-schizophrenic Drugs Product Offerings
Table 50. Sunovion Pharmaceuticals Anti-schizophrenic Drugs Revenue (US$, Mn), (2018-2023)
Table 51. Gedeon Richter Corporate Summary
Table 52. Gedeon Richter Anti-schizophrenic Drugs Product Offerings
Table 53. Gedeon Richter Anti-schizophrenic Drugs Revenue (US$, Mn), (2018-2023)
Table 54. Alkermes Corporate Summary
Table 55. Alkermes Anti-schizophrenic Drugs Product Offerings
Table 56. Alkermes Anti-schizophrenic Drugs Revenue (US$, Mn), (2018-2023)
Table 57. Indivior Corporate Summary
Table 58. Indivior Anti-schizophrenic Drugs Product Offerings
Table 59. Indivior Anti-schizophrenic Drugs Revenue (US$, Mn), (2018-2023)
Table 60. Alexza Pharmaceuticals Corporate Summary
Table 61. Alexza Pharmaceuticals Anti-schizophrenic Drugs Product Offerings
Table 62. Alexza Pharmaceuticals Anti-schizophrenic Drugs Revenue (US$, Mn), (2018-2023)
Table 63. Noven Pharmaceuticals Corporate Summary
Table 64. Noven Pharmaceuticals Anti-schizophrenic Drugs Product Offerings
Table 65. Noven Pharmaceuticals Anti-schizophrenic Drugs Revenue (US$, Mn), (2018-2023)
Table 66. Hisamitsu Pharmaceutical Corporate Summary
Table 67. Hisamitsu Pharmaceutical Anti-schizophrenic Drugs Product Offerings
Table 68. Hisamitsu Pharmaceutical Anti-schizophrenic Drugs Revenue (US$, Mn), (2018-2023)
Table 69. Zhejiang Huahai Corporate Summary
Table 70. Zhejiang Huahai Anti-schizophrenic Drugs Product Offerings
Table 71. Zhejiang Huahai Anti-schizophrenic Drugs Revenue (US$, Mn), (2018-2023)
Table 72. Chengdu Kanghong Pharmaceutical Corporate Summary
Table 73. Chengdu Kanghong Pharmaceutical Anti-schizophrenic Drugs Product Offerings
Table 74. Chengdu Kanghong Pharmaceutical Anti-schizophrenic Drugs Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Anti-schizophrenic Drugs Segment by Type in 2022
Figure 2. Anti-schizophrenic Drugs Segment by Application in 2022
Figure 3. Global Anti-schizophrenic Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-schizophrenic Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Anti-schizophrenic Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-schizophrenic Drugs Revenue in 2022
Figure 8. By Type - Global Anti-schizophrenic Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Anti-schizophrenic Drugs Revenue Market Share, 2018-2030
Figure 10. By Region - Global Anti-schizophrenic Drugs Revenue Market Share, 2018-2030
Figure 11. By Country - North America Anti-schizophrenic Drugs Revenue Market Share, 2018-2030
Figure 12. US Anti-schizophrenic Drugs Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Anti-schizophrenic Drugs Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Anti-schizophrenic Drugs Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Anti-schizophrenic Drugs Revenue Market Share, 2018-2030
Figure 16. Germany Anti-schizophrenic Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. France Anti-schizophrenic Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Anti-schizophrenic Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Anti-schizophrenic Drugs Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Anti-schizophrenic Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Anti-schizophrenic Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Anti-schizophrenic Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Anti-schizophrenic Drugs Revenue Market Share, 2018-2030
Figure 24. China Anti-schizophrenic Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Anti-schizophrenic Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Anti-schizophrenic Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Anti-schizophrenic Drugs Revenue, (US$, Mn), 2018-2030
Figure 28. India Anti-schizophrenic Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Anti-schizophrenic Drugs Revenue Market Share, 2018-2030
Figure 30. Brazil Anti-schizophrenic Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Anti-schizophrenic Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Anti-schizophrenic Drugs Revenue Market Share, 2018-2030
Figure 33. Turkey Anti-schizophrenic Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Anti-schizophrenic Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Anti-schizophrenic Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Anti-schizophrenic Drugs Revenue, (US$, Mn), 2018-2030
Figure 37. Pfizer Anti-schizophrenic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Johnson & Johnson Anti-schizophrenic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. AstraZeneca Anti-schizophrenic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Eli Lilly Anti-schizophrenic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Otsuka Pharmaceutical Anti-schizophrenic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Intra-Cellular Therapies Anti-schizophrenic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sunovion Pharmaceuticals Anti-schizophrenic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Gedeon Richter Anti-schizophrenic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Alkermes Anti-schizophrenic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Indivior Anti-schizophrenic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Alexza Pharmaceuticals Anti-schizophrenic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Noven Pharmaceuticals Anti-schizophrenic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Hisamitsu Pharmaceutical Anti-schizophrenic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Zhejiang Huahai Anti-schizophrenic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Chengdu Kanghong Pharmaceutical Anti-schizophrenic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
